clinical trial units
evaluation of CWB
guardians of patients
convalescent plasma
Emergency evaluation of convalescent blood
Ebola Viral Disease
feasibility of convalescent
proof of clinical efficacy
case fatality rate
CP
health-care workers
harmonized standard supportive care
present EVD epidemic
local partners
local actors
current context
study context
Written consent
available figures
non-governmental organizations
international research networks
West African countries
major public health implications
non-randomised open-label design
initial phase
treatment
highest standards attainable
intravenous hydration
adequate training
unique partnership of academics
therapy
human rights
consecutive phases
agreed stands of ethics
psycho-emotional support
shock management
safety
community communication
place
information
mortality
proposal
duration
Survival
primary outcome
intervention
Day
objective
consideration